Hot Tech Stocks To Own Right Now

Our top stock selection for 2014 has received three Breakthrough Therapy Designations (BTD) by the FDA, and subsequent approval, in November, for Imbruvica, a very safe pill that has shown unprecedented efficacy to treat mantle cell lymphoma (MCL), suggests John McCamant, editor of The Medical Technology Stock Letter.

The company��hich we consider conservative among biotech stocks��s Pharmacyclics (PCYC). Its pill is also expected to be approved for a much larger B-cell cancer market, chronic lymphocytic leukemia (CLL), by the end of February.

The next catalyst for PCYC will be the release of data, at the end of January, from the RESONATE trial, the first Phase III study of Imbruvica in patients with refractory/relapsed CLL. RESONATE should continue to demonstrate Imbruvica's incredible efficacy and safety as a once-a-day cancer pill.

With the drug already on the market for MCL, we expect CLL sales to ramp up rapidly, as there is a large pool of CLL patients that have been watching and waiting for a safe and effective treatment for CLL.

Best Electric Utility Companies To Watch In Right Now: Biogen Idec Inc(BIIB)

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t he treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer's disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.

Advisors' Opinion:

• [By Ben Levisohn]

  Credit Suisse analyst�Ravi Mehrotra�and team raised Celgene to�Outperform from Neutral, putting it on par with Outperform rated Biogen Idec (BIIB) and�Gilead�(GILD) and a notch above Neutral-rated Amgen (AMGN).�

• [By Polya Lesova]

  Biogen Idec Inc. (BIIB) �was the top gainer in the S&P 500. Its shares rallied 13% after the biotech company said Friday that the European Medicines Agency has determined that dimethyl fumarate in its multiple-sclerosis treatment Tecfidera qualifies as a new active substance. This designation will provide 10 years of regulatory exclusivity for the treatment in the European Union.

• [By Peter Stephens]

  In addition, sector peer Biogen (NASDAQ: BIIB  ) has received European Commission aproval for its new multiple sclerosis drug, Tecfidera, and will launch the product in H1 2014. The potential in Europe for the drug seems vast, since it has become the most prescribed pill for the treatment of multiple sclerosis in the U.S. since Biogen gained approval for it in 2013.

• [By Ben Levisohn]

  Today’s selloff� started when three Democratic Party congressmen challenged Gilead Sciences (GILD) pricing of its hepatitis C-drug Sovaldi. The indiscriminate selling of biotech stocks–Biogen Idec (BIIB), Celgene (CELG) and Regeneron (REGN) all dropped at least 3.7%–suggests that investors have itchy trigger fingers, says Bernstein’s Geoffrey Porges and team:

Hot Tech Stocks To Own Right Now: 3D Systems Corp. (DDD)

3D Systems Corporation, through its subsidiaries, engages in the design, development, manufacture, marketing, and servicing of 3D printers and related products, print materials, and services. The company�s principle print engines comprise stereolithography, selective laser sintering, multi-jet modeling, film transfer imaging, selective laser melting, and plastic jet printers. Its 3D printers convert data input from computer-aided design software or 3D scanning and sculpting devices to produce physical objects from engineered plastic, metal, and composite print materials. The company also blends, markets, sells, and distributes various consumables, engineered plastics, metal materials, and composites; and offers various software tools, as well as pre-sale and post-sale services, including applications development, installation, warranty, and maintenance. In addition, it provides custom parts services, such as precision plastic and metal parts service and assembly capabilit ies. The company markets its stereolithography materials under the Accura and RenShape; laser sintering materials under the DuraForm, CastForm, and LaserForm; and materials for professional printers under the VisiJet brands. It primarily serves manufacturers of automotive, aerospace, computer, electronic, defense, education, consumer, energy and healthcare products, as well as original equipment manufacturers, government agencies, universities, and independent service bureaus. The company sells its products and services through its direct sales organization, sales agents, resellers, and distributors primarily in the United States, Europe, and the Asia-Pacific region. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.

Advisors' Opinion:

• [By Paul Ausick]

  3D Systems Inc. (NYSE: DDD) is the largest of the 3D printing firms based on its market value of $6.83 billion as of Friday�� close. Shares closed up about 2.6% at $66.44 in a 52-week range of $27.88 to $97.28. The consensus price target on the stock is $81.41 which implies a potential upside of about 22.6% to Friday�� closing price. The forward P/E ratio for 2015 is nearly 69. The company is scheduled to report 2013 results on February 28; analysts are looking for full-year earnings per share (EPS) of $0.89 on revenue of $513.66 million. Last week, 3D Systems lowered its EPS and revenue estimates for 2013 and forecast 2014 earnings below the consensus estimate.

• [By Ant贸nio Costa]
  3D Systems Corporation (NYSE: DDD) is a potential breakout play for next week. Momentum picking up with RSI climbing and MACD about to cross its signal line from below. Two resistance points can be noted on daily chart, first is at 82.65, second at 84.85. As long as the stock trades above its major rising EMAs, stay invested in the stock and enjoy the ride. ( click to enlarge )

• [By Rick Munarriz]

  5. Put on your rose-colored 3-D glasses�
  3D Systems (NYSE: DDD  ) was able to fire back at skeptics arguing that the hype over 3-D printing is overblown by delivering strong growth in its latest quarter.

Hot Tech Stocks To Own Right Now: Silicon Graphics International Corp(SGI)

Silicon Graphics International Corp. provides computing and storage, and data center solutions, as well as related customer support and professional services. The company offers scale up servers; scale out servers; work group servers; data storage systems; and software products for technical computing, as well as data center infrastructure products, including ICE Cube Air, a modular data center that augments or replaces traditional brick-and-mortar data centers; and MobiRack, a line of mobile, all-in-one data center cabinets for field deployments. Its products and services are used by the scientific, technical, and business communities for solving challenging data-intensive computing, data storage, and management problems. The company also develops system applications, such as simulating global climate changes, accelerating engineering of new automotive designs, supporting homeland security initiatives, real-time fraud detection, streaming media from Internet-video to film , and gaining business intelligence through data-mining to defense and strategic systems, weather and climate, physical and life sciences, energy, aerospace and automotive, media and entertainment, semiconductor design and manufacturing, financial services, data centers, and business intelligence and data analytics markets; and enterprise class features for the Linux operating system that provide a standard Linux operating environment. Silicon Graphics International Corp. markets and sells its systems, technologies, software, and services to enterprises in approximately 25 countries through direct and indirect sales force, including distributors, original equipment manufacturers, system integrators, value added resellers, and channel partners. The company was formerly known as Rackable Systems, Inc. and changed its name to Silicon Graphics International Corp. in May 2009. Silicon Graphics International Corp. was incorporated in 2002 and is headquartered in Fremont, Californi a.

Advisors' Opinion:

• [By Roberto Pedone]

   

  Silicon Graphics International (SGI) develops, markets and sells various servers, enterprise-class storage hardware, differentiating software and solutions. This stock closed up 3.3% to $9.36 in Thursday's trading session.

   

  Thursday's Range: $9.07-$9.47
  
  52-Week Range: $8.16-$16.60
  
  Thursday's Volume: 179,000
  
  Three-Month Average Volume: 270,564

   

  From a technical perspective, SGI bounced notably higher here right above some near-term support at $9 with lighter-than-average volume. This stock has been making higher lows over the last two months, and this stock is now starting to trend within range of triggering a near-term breakout trade. That trade will hit if SGI manages to take out some near-term overhead resistance levels at its 50-day moving average of $9.58 to some more near-term overhead resistance levels at $9.65 to $10.23 with high volume.

   

  Traders should now look for long-biased trades in SGI as long as it's trending above some near-term support levels at $9 or at $8.86 and then once it sustains a move or close above those breakout levels with volume that hits near or above 270,564 shares. If that breakout hits soon, then SGI will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $10.83 to its gap-down-day high of $11 from May. Any high-volume move above $11 will then give SGI a chance to re-fill some of its previous gap-down-day zone that started near $12.50.

   

• [By Robert Abbott]

  President & Chief Executive Officer: Mark J. Barrenechea has held these positions since January 2012; previously, he was President, CEO, and a Director of Silicon Graphics International (SGI), and prior to that held senior management positions at CA. Inc (formerly Computer Associates International, Inc. (CA). Mr. Barrenechea is also a Director of OpenText.

Hot Tech Stocks To Own Right Now: Leapfrog Enterprises Inc(LF)

LeapFrog Enterprises, Inc. designs, develops, and markets technology-based learning platforms and related proprietary content primarily for infants and children worldwide. The company offers interactive reading systems, such as the Tag reading system that focuses on fundamental reading skills and offers a library of software-based books; and Tag Junior reading system used for the introduction of younger children to books and reading. It also provides mobile learning system products, including Leapster platform, a handheld device with a multi-directional control pad and a touch-screen enabled by a built-in stylus; Leapster2 platform, a Web-connected version of Leapster; and Leapster Explorer to download digital content, such as games, e-Books, videos and flash cards. In addition, the company offers Scout collection, a line of learning toys that are Web-enabled and connect to the Learning Path; and My Own Leaptop, a Web-enabled customizable laptop; Fridge Collection, a line of magnetic learning toys that introduce letter names, letter sounds, spelling, and songs; Learn and Groove Collection, which include bilingual musical learning toys; and various products that address basic learning needs and milestones. Further, it provides LeapFrog Learning Path, an online tool enabling parents to track what their children are learning with Web-connected products; and LeapWorld, which allows children to play online games, customize their mobile learning and gaming experiences, access new content, watch trailers for new games, and view demonstrations. It sells its products directly to national and regional mass-market and specialty retailers; other retail stores and distributors; school-related distributors and resellers; and through online store and other Internet-based channels. The company was founded in 1995 and is headquartered in Emeryville, California. LeapFrog Enterprises, Inc. is a subsidiary of Mollusk Holdings, LLC.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  Paul Sakuma/AP There were plenty of winners and losers this week, with a few potential mergers coming undone and a maker of electronic learning toys getting schooled. Here's a rundown of the week's smartest moves and biggest blunders. Trex (TREX) -- Winner It's summer, and apparently a lot of homeowners decided to invest in sprucing up their outdoor living space. Trex posted strong quarterly results on Monday. The leading maker of weather-resistant wood-alternative decking saw its sales climb 23 percent, and adjusted pre-tax earnings soared 62 percent. There was some weakness earlier this earnings season out of other home improvement specialists, so it's a welcome surprise to see Trex holding up so well. The good news doesn't end there. Trex is eyeing accelerating growth, calling for revenue to climb a better than expected 27 percent in the current quarter. Mergers -- Loser In any week there seems to be a couple of acquisitions or mergers, but sometimes Cupid isn't feeling up to the arrow-slinging task. A couple of big potential buyouts came undone this week when Rupert Murdoch pulled his offer to buy out Time Warner (TWX), and Sprint (S) nixed plans to snap up T-Mobile (TMUS). The deals fell apart for different reasons. Murdoch just didn't have an interest in chasing Time Warner's stock higher in a hostile buyout bid. Sprint realized that regulators weren't going to be happy unless there were four major independent wireless carriers out there. Instant Gratification -- Winner Amazon.com (AMZN) announced on Wednesday that it was expanding its same-day delivery service to six more cities. Prime shoppers in Baltimore, Dallas, Indianapolis, New York City, Philadelphia and Washington, DC, metro areas will now be able to place an order on the website by noon and pay $5.99 to have it delivered that same day. Naturally the selection is limited to items that Amazon stocks locally, but the one knock on Amazon about having to wait a day or two at least for shipme

• [By Steve Symington]

  Whole Foods�Market (NASDAQ: WFM  ) --�"America's healthiest grocery store"
  The team at Whole Foods has long made clear their mission, which includes holding to a central list of core values�they describe as the steady "underpinning of our company culture." Among the items on that list are "selling the highest quality natural and organic products available," "satisfying and delighting our customers," "supporting team member excellence and happiness," "caring about our communities and our environment," and "creating wealth through profits and growth."

  Of course, many investors are most excited about that last item, and Whole Foods has certainly delivered on that promise by helping early shareholders return more than 36 times their initial investment over the past 20 years. Even so, I think Whole Foods has plenty of growth left, so I put my money where my mouth is and�bought Whole Foods stock for the first time last month. � LeapFrog (NYSE: LF  ) --�"We put learning first -- a philosophy that distinguishes us from our competitors and fuels the entire company."
  Anyone who has kids knows how effective LeapFrog's products can be. In fact, my own children frequently request LeapFrog's educational programs on Netflix. Even better, our 2-year-old surprised us earlier this year by recognizing and saying the name of every letter in the alphabet as I randomly pointed them out -- something we had worked on a little, but with which I'm sure LeapFrog lent its helping hand.

  If that weren't enough, the company also managed to beat first-quarter earnings estimates earlier this month, is�generating tons of cash, and looks cheap, as it currently trades for just 13 times next year's estimated earnings.

Hot Tech Stocks To Own Right Now: Cannabis Science Inc (CBIS)

Cannabis Science, Inc., incorporated on May 4, 2007, is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health maintenance. On February 9, 2012, the Company acquired GGECO University, Inc. (GGECO). On March 21, 2012, the Company acquired Cannabis Consulting Inc. (CCI Group).

The Company is engaged in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

Advisors' Opinion:

• [By Dan Burrows]

  But it doesn’t end there. Investors should run away from all OTC marijuana stocks, including Medical Marijuana (MJNA), Cannabis Science (CBIS), CannaVest (CANV), MediSwipe (MWIP) and GreenGro Technologies (GRNH). As the SEC warns:

• [By Dan Burrows]

  MediSwipe (MWIP) has tripled, with MWIP stock up 200%. Cannabis Science (CBIS) is closing in on quadrupling, as CBIS stock gained 273%. And GreenGro Technologies (GRNH)? Brace yourself, because GRNH stock is up over 1,000% … including an 18% so far today.

• [By Bryan Murphy]

  There's no denying it. Marijuana stocks like Cannabis Science Inc. (OTCMKTS:CBIS), Growlife Inc. (OTCBB:PHOT), and Medical Marijuana Inc. (OTCMKTS:MJNA) have gotten their second wind (and some would argue their third wind) over the past few days, doling out big gains in a very short period of time. MJNA is up 88% over the past four trading days, counting today. PHOT has popped 44% during that timeframe. CBIS has advanced 91% in just six days. It's everything a devoted shareholder of any of these companies could hope for, and more.

• [By Bryan Murphy]

  Much like Nuvilex, Cannabis Science Inc. (OTCMKTS:CBIS) appears to simply be another conventional biotech outfit. And, truth be told, that's what CBIS is. It just happens to be developing two drugs based on cannabinoids... one to reat HIV/AIDS, and the other to treat cancer. Both drugs are in preclinical trials right now, so an actual marketable product is still years down the road for Cannabis Science Inc. But, as a legitimate biotechnology that isn't aiming to simply fuel tokers' needs, it's not going to hit any regulatory or law-enforcement roadblocks.

Hot Tech Stocks To Own Right Now: Intevac Inc.(IVAC)

Intevac, Inc. provides process manufacturing equipment solutions to the hard disk drive industry, and process manufacturing equipment and inspection solutions to the photovoltaic industry. The company operates in two segments, Equipment and Intevac Photonics. The Equipment segment designs, develops, and markets magnetic disks; hard disk drive equipment products, including disk sputtering and disk lubrication systems; technology upgrades; and spare parts and consumables, as well as installation, maintenance, and repair services. This segment also offers capital equipment for the photovoltaic solar manufacturing industry. The Intevac Photonics segment develops, manufactures, and sells digital-optical products for the capture and display of low-light images and materials identification used in military aircraft, ground vehicles, ground soldier head-mounted, and weapon-mounted applications. This segment also provides sensors, cameras, and systems for military applications; Ram an spectrometer table-top and handheld systems for use in forensics, homeland security, geology, gemology, medical, pharmaceutical, and industrial quality assurance applications; and low-light cameras for industrial inspection, bio-medical, and scientific applications. The company sells its products through direct sales force, system integrators, distributors, and value added resellers in the United States, Asia, Europe, and rest of world. Intevac, Inc. was founded in 1990 and is headquartered in Santa Clara, California.

Advisors' Opinion:

• [By Roberto Pedone]

  Intevac (IVAC) provides process manufacturing equipment solutions to the hard disk drive industry and high-productivity process manufacturing equipment and inspection solutions to the photovoltaic industry. This stock closed up 8.5% to $6.74 in Tuesday's trading session.

  Tuesday's Range: $6.23-$6.75
  
  52-Week Range: $4.06-$6.80
  
  Tuesday's Volume: 263,000
  
  Three-Month Average Volume: 140,032

  From a technical perspective, IVAC soared higher here right off some near-term support at $6.25 with above-average volume. This stock has been uptrending strong for the last three months, with shares moving higher from its low of $4.31 to its recent high of $6.80. During that move, shares of IVAC have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IVAC within range of triggering a major breakout trade. That trade will hit if IVAC manages to take out its 52-week high at $6.80 with high volume.

  Traders should now look for long-biased trades in IVAC as long as it's trending above some near-term support levels at $6.25 or at $5.92 and then once it sustains a move or close above its 52-week high at $6.80 with volume that hits near or above 140,032 shares. If that breakout hits soon, then IVAC will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $8 to $8.37. Any high-volume move above those levels will then put $9 to $9.36 within range for shares of IVAC.